Odyssean »

10x Genomics Inc Cl A shares owned by Odyssean

Quarter-by-quarter ownership of 10x Genomics Inc Cl A (TXG) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in 10x Genomics Inc Cl A

Tip: Access up to 7 years of quarterly data

All positions including 10x Genomics Inc Cl A held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 10x Genomics Inc Cl A by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5M 38k 38.34

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding 10x Genomics Inc Cl A

FMR
ARK Investment Management
BlackRock
Vanguard Portfolio Management
Quantinno Capital Management
Nikko Asset Management Americas
Vanguard Capital Management
Sumitomo Mitsui Trust Holdings
Goldman Sachs Group
Citadel Advisors
Geode Capital Management
Morgan Stanley
State Street Corporation
AQR Capital Management
Millennium Management

View all funds holding 10x Genomics Inc Cl A